Pattern of uveitis in Behçet's disease in a referral center in Tunisia, North Africa

International Ophthalmology

Volumn 29, Issue 3, 2009, Pages 135-141

  Khairallah, Moncef ^a   Attia, Sonia ^a   Yahia, Salim Ben ^a   Jenzeri, Salah ^a   Ghrissi, Rim ^a   Jelliti, Bechir ^a   Zaouali, Sonia ^a   Messaoud, Riadh ^a  

^a FATTOUMA BOURGUIBA UNIVERSITY HOSPITAL   (Tunisia)

Author keywords

Beh et's uveitis; Epidemiology; North Africa; Tunisia

Indexed keywords

AZATHIOPRINE; COLCHICINE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; TRIAMCINOLONE ACETONIDE;

ADOLESCENT; ADULT; ARTICLE; BEHCET DISEASE; CATARACT; CLINICAL FEATURE; CONTROLLED STUDY; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG HYPERSENSITIVITY; DRUG PULSE THERAPY; DRUG RESPONSE; EYE DISEASE; EYE SYNECHIA; FEMALE; FOLLICULITIS; HUMAN; HYPOPYON; IMMUNOSUPPRESSIVE TREATMENT; INTRAOCULAR HEMORRHAGE; INTRAOCULAR PRESSURE ABNORMALITY; LASER COAGULATION; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MONOTHERAPY; MOUTH ULCER; NEOVASCULAR GLAUCOMA; ONSET AGE; OPTIC NERVE ATROPHY; PHTYSIS BULBI; PROGNOSIS; PSEUDOFOLLICULITIS; RETINA DETACHMENT; RETINA MACULA CYSTOID EDEMA; RETINA NEOVASCULARIZATION; RETINA VASCULITIS; RETINITIS; RETROSPECTIVE STUDY; SEX DIFFERENCE; SYSTEMIC THERAPY; TUNISIA; UNSPECIFIED SIDE EFFECT; UVEITIS; VISUAL ACUITY;

ADOLESCENT; ADRENAL CORTEX HORMONES; ADULT; AGE DISTRIBUTION; AGE OF ONSET; BEHCET SYNDROME; FEMALE; HOSPITALS, UNIVERSITY; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; RETINAL VASCULITIS; SEX DISTRIBUTION; TUNISIA; UVEITIS; VISUAL ACUITY;

EID: 67349175296     PISSN: 01655701     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10792-008-9203-9     Document Type: Article

References (27)

1. Evereklioglu G (2005) Current concepts in the etiology and treatment of Behçet disease. Surv Ophthalmol 50:297-350
2. Sakane T, Takeno M, Suzuki N et al (1999) Behçet's disease. N Engl J Med 341:1284-1291
3. Yoshida A, Kawashima H, Motoyama Y et al (2004) Comparison of patients with Behçet's disease in the 1980s and 1990s. Ophthalmology 111:810-815
4. B'chir Hamzaoui S, Harmel A, Bouslama K et al (2006) Behçet's disease in Tunisia. Clinical study of 519 cases. Rev Med Interne 27:742-750
5. Khairallah M, Ben Yahia S, Ladjimi A et al (2007) Pattern of uveitis in a referral centre in Tunisia, North Africa. Eye Jan 21(1):33-39
6. Zouboulis CC, Kötter I, Djawari D et al (1997) Epidemiological features of Amantiades-Behçet's disease in Germany and in Europe. Yonsei Med J 38:411-422
7. Muhaya M, Lightman S, Ikeda E et al (2000) Behcet's disease in Japan and in Great Britain: A comparative study. Ocul Immunol Inflamm 8:141-148
8. Demiroglu H, Barista I, Dundar S (1997) Risk factor assessment and prognosis of eye involvement in Behçet's disease in Turkey. Ophthalmology 104:701-705
9. Ozdal PC, Ortac S, Taskintuna I et al (2002) Posterior segment involvement in ocular Behcet's disease. Eur J Ophthalmol 12:424-431
10. Ambresin A, Tao Tran V, Spertini F et al (2002) Behçet's disease in western Switzerland: Epidemiology and analysis of ocular involvement. Ocul Immunol Inflamm 10:53-63
11. Tugal-Tutkun I, Onal S, Yaycioglu AR et al (2004) Uveitis in Behçet disease: An analysis of 880 patients. Am J Ophthalmol 138:373-380
12. Yang P, Fang W, Meng Q et al (2008) Clinical features of Chinese patients with Behçet's disease. Ophthalmology 115:312-318
13. Daghfous MT, Ammar M, Kamoun M et al (1980) Clinical aspects and course of Adamantiades Behcet's disease in Tunisia: A report on 41 cases. J Fr Ophtalmol 3(8-9):463-468
14. Ouazzani B, Benchekroun N, El Aouni A et al (1995) Outcome of Behcet disease in ophthalmological milieu in Morocco. J Fr Ophtalmol 18(2):124-127
15. International Study Group for Behçet's Disease (1990) Evaluation of diagnostic ('classification') criteria in Beçet's disease: toward internationally agreed criteria. Lancet 335:1078-1080
16. Jabs DA, Nussenblatt RB, Rosenbaum JT (2005) Standardization of uveitis nomenclature for reporting clinical data. Results of the first international workshop. Am J Ophthalmol 140(3):509-516
17. Sakamoto M, Akazawa K, Nishioka Y et al (1995) Prognosis factors of vision in patients with Behçet disease. Ophthalmology 102:317-321
18. Krause L (2005) Adamantiades-Behcet's disease. Ophthalmologe 102:329-334
19. Yazici H, Yurdakul S, Hamuryudan V (1999) Behçet's syndrome. Curr Opin Rheumatol 11:53-57
20. Barra C, Belfort R, Abreu MT et al (1991) Behçet's disease in Brazil: A review of 49 cases with emphasis on ophthalmic manifestations. Jpn J Ophthalmol 35:339-346
21. BenEzra D, Cohen E (1986) Treatment and visual prognosis in Behçet's disease. Br J Ophthalmol 70:589-592
22. Lardenoye C, Kooij B, Rothova A (2006) Impact of macular edema on visual acuity in uveitis. Ophthalmology 113:1446-1449
23. Mochizuki M (1998) Up-to-date treatment for Behçet's disease. Asian Med J 41:320-325
24. Kitaichi N, Miyazaki A, Stanford MR et al (2007) Ocular feartures of Behçet's disease: An international collaborative study. Br J Ophthalmol 91:1579-1582
25. Tugal-Tutkun I, Mudun A, Urgancioglu M et al (2005) Efficacy of infliximab in the treatment of uveitis that is resistant to treatment with the combination of azathioprine, cyclosporine, and corticosteroids in Behçet's disease: An open-label trial. Arthritis Rheum 52(8):2478-2484
26. Accorinti M, Pirraglia MP, Paroli MP et al (2007) Infliximab treatment for ocular and extraocular manifestations of Behçet's disease. Jpn J Ophthalmol 51(3):191-196
27. Gul A (2007) Standard and novel therapeutic approaches to Behcet's disease. Drugs 67(14):2013-2022